| 000 | 01013 a2200277 4500 | ||
|---|---|---|---|
| 005 | 20250515134356.0 | ||
| 264 | 0 | _c20081023 | |
| 008 | 200810s 0 0 eng d | ||
| 022 | _a1744-8395 | ||
| 024 | 7 |
_a10.1586/14760584.7.7.895 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aInsinga, Ralph P | |
| 245 | 0 | 0 |
_aStructural differences among cost-effectiveness models of human papillomavirus vaccines. _h[electronic resource] |
| 260 |
_bExpert review of vaccines _cSep 2008 |
||
| 300 |
_a895-913 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Meta-Analysis | ||
| 650 | 0 | 4 | _aCost-Benefit Analysis |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aModels, Theoretical |
| 650 | 0 | 4 |
_aPapillomavirus Infections _xeconomics |
| 650 | 0 | 4 |
_aPapillomavirus Vaccines _xeconomics |
| 700 | 1 | _aDasbach, Erik J | |
| 700 | 1 | _aElbasha, Elamin H | |
| 773 | 0 |
_tExpert review of vaccines _gvol. 7 _gno. 7 _gp. 895-913 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1586/14760584.7.7.895 _zAvailable from publisher's website |
| 999 |
_c18237945 _d18237945 |
||